Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.66.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 23 comparable quarters.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-7.29
EARNINGS PER SHARE (EPS) AVG 3Y
-67.66
EARNINGS PER SHARE (EPS) AVG 5Y
-178.24
EARNINGS PER SHARE (EPS) AVG 10Y
-808.36
EARNINGS PER SHARE (EPS) AVG 15Y
-3490.47
EARNINGS PER SHARE (EPS) AVG 20Y
-59172.93
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Eloxx Pharmaceuticals, Inc.
Market Cap
$52.95M
Earnings Per Share (EPS)
N/A
TTM Avg
-7.29
3Y Avg
-67.66
5Y Avg
-178.24
Market Cap
$53.01M
Earnings Per Share (EPS)
-5.21
TTM Avg
-25.08
3Y Avg
-23.14
5Y Avg
-19.79
Market Cap
$51.58M
Earnings Per Share (EPS)
-0.69
TTM Avg
-1.98
3Y Avg
-1.79
5Y Avg
-1.67
Market Cap
$51.23M
Earnings Per Share (EPS)
-1.20
TTM Avg
-0.91
3Y Avg
-0.56
5Y Avg
-0.48
Market Cap
$51.12M
Earnings Per Share (EPS)
-8.95
TTM Avg
-8.42
3Y Avg
-12.89
5Y Avg
-25.33
Market Cap
$50.51M
Earnings Per Share (EPS)
N/A
TTM Avg
-30.18
3Y Avg
-88.49
5Y Avg
-66.35
Market Cap
$50.25M
Earnings Per Share (EPS)
-0.67
TTM Avg
-1.36
3Y Avg
-1.71
5Y Avg
-1.31
Market Cap
$55.72M
Earnings Per Share (EPS)
-0.39
TTM Avg
-0.75
3Y Avg
-0.80
5Y Avg
-0.90
Market Cap
$49.96M
Earnings Per Share (EPS)
-3.55
TTM Avg
-4.16
3Y Avg
-5.92
5Y Avg
-5.28
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | $52.95M | N/A | -7.29 | -67.66 | -178.24 |
| ImageneBio Inc (IMA)vs › | $53.01M | -5.21 | -25.08 | -23.14 | -19.79 |
| INmune Bio, Inc. (INMB)vs › | $51.58M | -0.69 | -1.98 | -1.79 | -1.67 |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | -1.20 | -0.91 | -0.56 | -0.48 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | -8.95 | -8.42 | -12.89 | -25.33 |
| Apollomics, Inc. (APLM)vs › | $50.51M | N/A | -30.18 | -88.49 | -66.35 |
| Envoy Medical, Inc. (COCH)vs › | $50.25M | -0.67 | -1.36 | -1.71 | -1.31 |
| Aldeyra The (ALDX)vs › | $55.72M | -0.39 | -0.75 | -0.80 | -0.90 |
| Clene Inc. (CLNN)vs › | $49.96M | -3.55 | -4.16 | -5.92 | -5.28 |
| Celularity Inc. (CELU)vs › | $49.50M | -2.83 | -3.12 | -4.06 | -22.86 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
$-2.10
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -5.34 |
| 2024-12-31 | -9.24 |
| 2023-12-31 | -72.93 |
| 2022-12-31 | -183.13 |
| 2021-12-31 | -419.65 |
| 2020-12-31 | -379.16 |
| 2019-12-31 | -588.09 |
| 2018-12-31 | -640.06 |
| 2017-12-31 | -2090.00 |
| 2016-06-30 | -3696.00 |
| 2015-06-30 | -11538.00 |
| 2014-06-30 | -22264.00 |
| 2013-06-30 | -44000.00 |
| 2012-06-30 | -70400.00 |
| 2011-06-30 | -123200.00 |
| 2010-06-30 | -589600.00 |
| 2009-06-30 | -264000.00 |
| 2008-06-30 | -228800.00 |
| 2007-06-30 | -167200.00 |
| 2006-06-30 | -184800.00 |
| 2005-06-30 | -184800.00 |
| 2004-06-30 | -211200.00 |
